Multiple Sclerosis, Secondary Progressive
Information
- Disease name
- Multiple Sclerosis, Secondary Progressive
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT00888277 | Completed | Bayer/Cognitive Assessments With Multiple Sclerosis Subjects | May 2009 | January 2010 | |
| NCT01982942 | Completed | Phase 2 | Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis | November 2013 | December 2017 |
| NCT06436131 | Completed | N/A | The Effects of In-phase Bilateral Exercise in People With Progressive Multiple Sclerosis | October 2, 2023 | December 22, 2023 |
| NCT05357833 | Completed | Early Phase 1 | Novel Imaging Markers in SPMS | June 1, 2022 | September 1, 2023 |
| NCT02988401 | Completed | Phase 1/Phase 2 | Intranasal Insulin for Improving Cognitive Function in Multiple Sclerosis | December 1, 2017 | December 17, 2021 |
| NCT03653585 | Completed | Cortical Lesions in Patients With Multiple Sclerosis | September 4, 2018 | September 3, 2020 | |
| NCT04211740 | Completed | Phase 2 | Phase II Clinical Trial of OCH-NCNP1 | December 6, 2019 | May 31, 2023 |
| NCT01433497 | Completed | Phase 3 | Efficacy and Safety of Masitinib in the Treatment of Progressive Multiple Sclerosis | August 2011 | February 2020 |
| NCT02305264 | Completed | N/A | Imaging of Intracerebral Inflammation in MS | March 19, 2012 | September 10, 2018 |
| NCT05663853 | Completed | An Observational Biomarker Study in Multiple Sclerosis (MS) Patients | March 28, 2023 | April 30, 2024 | |
| NCT02308137 | Completed | Phase 2 | Domperidone in Secondary Progressive Multiple Sclerosis (SPMS) | February 2015 | January 3, 2020 |
| NCT00587691 | Completed | Phase 1/Phase 2 | Dose-Escalation Study of T Cell Vaccine in Multiple Sclerosis | July 2002 | December 2008 |
| NCT02506751 | Completed | Phase 1 | Open-label Study of Liothyronine in MS | July 2015 | September 18, 2017 |
| NCT05385731 | Not yet recruiting | N/A | MUSCLE - Nordic Walking in MUltiple SCLErosis | August 2, 2022 | December 30, 2024 |
| NCT06384976 | Not yet recruiting | Phase 2 | A Study of Anti-CD19 CAR T-Cell Therapy, in Subjects With Refractory Primary and Secondary Progressive Multiple Sclerosis | April 2024 | January 2029 |
| NCT06390930 | Not yet recruiting | N/A | Effects of Acute Intermittent Hypoxia on Neuroplasticity in MS | July 2024 | July 2027 |
| NCT06413602 | Not yet recruiting | N/A | The Synergistic Effects of AIH and FES in Persons With MS | August 2024 | August 2027 |
| NCT06138132 | Recruiting | Phase 1 | A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell ( CAR-T) Therapy in Subjects With Non-relapsing and Progressive Forms of Multiple Sclerosis | April 10, 2024 | June 2027 |
| NCT04918225 | Recruiting | Motor Asymmetry in Progressive Multiple Sclerosis Patients | November 3, 2021 | May 2026 | |
| NCT05013463 | Recruiting | Phase 2 | Hydroxychloroquine and Indapamide in SPMS | October 1, 2021 | September 1, 2024 |
| NCT05122559 | Recruiting | Phase 2 | Neuroprotection With N-acetyl Cysteine for Patients With Progressive Multiple Sclerosis | February 16, 2022 | February 2026 |
| NCT05168384 | Recruiting | Phase 1/Phase 2 | Safety and Efficacy of Extracorporeal Photopheresis (ECP) in the Treatment of Multiple Sclerosis | March 26, 2022 | June 2025 |
| NCT05204459 | Recruiting | MS-ResearchBiomarkerS | November 11, 2021 | November 11, 2041 | |
| NCT05496881 | Recruiting | N/A | Exercise Effects in Multiple Sclerosis | June 15, 2022 | April 30, 2025 |
| NCT05961644 | Recruiting | Phase 2/Phase 3 | Cladribine vs Placebo for Non-active Progressive Multiple Sclerosis (CLASP-MS). | October 3, 2022 | October 30, 2027 |
| NCT06276634 | Recruiting | N/A | Intermittent Hypoxia in Persons With Multiple Sclerosis | April 30, 2024 | January 2027 |
| NCT00468611 | Terminated | Phase 3 | Efficacy and Safety of MBP8298 in Subjects With Secondary Progressive Multiple Sclerosis | June 2007 | September 2009 |
| NCT02430532 | Terminated | Phase 3 | BG00012 and Delay of Disability Progression in Secondary Progressive Multiple Sclerosis | May 2015 | January 2016 |
| NCT04993274 | Unknown status | Sensitivity of Motor Assessment in MS - a Prospective Cohort Study | February 20, 2019 | November 2022 | |
| NCT04260711 | Unknown status | N/A | Discontinuing Disease-modifying Therapies in Stable Relapsing - Onset Multiple Sclerosis (DOT-MS). | July 1, 2020 | January 1, 2024 |
| NCT02273635 | Unknown status | Phase 1/Phase 2 | Efficacy, Safety and Tolerability of Andrographolides Versus Placebo in Patients With Progressive Forms of MS | September 2014 | April 2017 |